QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
2 hedge funds and large institutions have $730K invested in QIAGEN NV in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Fund Management (CFM)
Paris,
France
|
+$493K |
| 2 |
ACM
ADI Capital Management
New York
|
+$237K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Capital Fund Management (CFM)
Paris,
France
| $493K | +$493K | +14,600 | New |
|
|
ACM
2
ADI Capital Management
New York
| $237K | +$237K | +7,000 | New |
|
QGENF Hedge Fund Activity: Q4 2019 in Review
2 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q4 2019, worth a combined $730K.
Buyers outnumbered sellers: 2 funds opened new QGENF positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Capital Fund Management (CFM), opening a new position worth an estimated $493K.
- 2 institutional investors held QIAGEN NV (QGENF) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $730K of QIAGEN NV stock for Q4 2019.
- 2 funds opened new QIAGEN NV positions in Q4 2019 and 0 closed out, a net change of +2 holders.
- The largest QIAGEN NV buyer in Q4 2019 was Capital Fund Management (CFM), an estimated $493K added.
Based on aggregated 13F filings for Q4 2019.